$20M Biotech Hub Coming To Brooklyn Navy Yard

State of the city 2023 speech
New York City Mayor Eric Adams During His 2023 State Of The City Address.

New York City plans to invest $20M in a biotech incubator in Brooklyn as part of a wide-ranging series of zoning and development initiatives meant to revive the city’s real estate market and incubate its growing life sciences sector.

Mayor Eric Adams announced the plan earlier this week and underscored it during his State of the City address Thursday.

“This year, the city will kick-start a new effort to become the global center of sustainable biotech,” Adams said during his speech. “We will start by opening a first-in-the-nation incubator at the Brooklyn Navy Yard, where biotech startups will transform the way we eat, build and protect our environment.”

The 50K SF space, expected to open in the next few years, will be operated by Newlab, an existing tech cluster in the Navy Yard, and offer office and lab space to biotech startups focused on consumer and industrial uses, especially related to new materials and food products. It’s meant to augment existing spaces and facilities that focus more on medical and medical diagnostic advances.

The hub will consist of step-up space, with the aim of helping growing companies stay in the city,  Partnership Fund for New York City CEO Maria Gotsch said. She believes the unique focus on seeding science and new products attractive to industries with strong roots in the city, such as food, design and fashion, will help play on the city’s strengths.

“We believe that New York City has tremendous potential to be a leader in life science,” Gotsch said. “A number of the innovations coming are relevant to large corporations, which are residents of New York City. We want to take the assets we have and convert it into innovation.”

Growing the biotech sector has been a key city policy goal. Former Mayor Bill de Blasio directed $1B in funding for the sector via his LifeSci NYC program, which is the source of the funds for the incubator announced today.

The city’s biotech sector has seen increased funding and investment in recent years, with a 2021 study by the Partnership Fund for New York City suggesting the sector had entered a “high-growth phase.”

Recent CBRE data found leasing activity in the city reached a record high in 2022, and new investments bring the total number of active or in-development incubators to nine. But many analysts have said the city and region haven’t yet achieved critical mass, due in part to the cost of lab real estate and challenges coordinating between city and suburban planners.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's National Newsletters
Related Stories

Revolution Medicines Nearing Agreement For 700K SF Lease In Redwood City

Trump's New Canadian Tariffs To Spike Additional Materials Costs

Pace Of NYC Housing Construction Plunges As Developers Play Small Ball

Alexandria Sells Cambridge Lab Condo Units For $45M

Wells Fargo Moves To Foreclose On $1.3B Workspace Property Trust Portfolio

Turner Construction Hit With Cyberattack, Hackers Claim Leaks Of Military Info, NDAs

Latest Round Of Fannie Mae Senior Staff Layoffs Has Multifamily Sector Anxious

Why Hines Is Restarting Its Development Engine

How Integrated Infrastructure Can Help AI Data Centers Deploy Faster, Build Smarter

Nvidia Buys Stake In Data Center Power Company

Invesco Cuts Fees, Adds Incentives To Quell Fund Redemption Requests

Investors Anchor Big Capital Into Marinas, Betting On Shallow Supply